T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.

Naturally processed MHC class II-bound peptides possess ragged NH2 and COOH termini. It is not known whether these peptide flanking residues (PFRs), which lie outside the MHC anchor residues, are recognized by the TCR or influence immunogenicity. Here we analyzed T cell responses to the COOH-terminal PFR of the H-2A(k) immunodominant epitope of hen egg lysozyme (HEL) 52-61. Surprisingly, the majority of T cells were completely dependent on, and specific for, the COOH-terminal PFR of the immunogen. In addition, there were striking correlations between TCR V beta usage and PFR dependence. We hypothesize that the V alpha CDR1 region recognizes NH2-terminal PFRs, while the V beta CDR1 region recognizes COOH-terminal PFRs. Last, peptides containing PFRs were considerably more immunogenic and mediated a greater recall response to the HEL protein. These results demonstrate that PFRs, which are a unique characteristic of peptides bound to MHC class II molecules, can have a profound effect on TCR recognition and T cell function. These data may have important implications for peptide-based immunotherapy and vaccine development.

[1]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[2]  S. Spencer,et al.  Two monoclonal antibodies specific for the T cell receptor Vα8 , 1989 .

[3]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[4]  J. Strominger,et al.  Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules , 1993, European journal of immunology.

[5]  S. Nathenson,et al.  Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule. , 1995, Immunity.

[6]  P. Allen,et al.  Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.

[7]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[8]  E. Unanue,et al.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[10]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[11]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[12]  Y. Chien,et al.  How alpha beta T-cell receptors 'see' peptide/MHC complexes. , 1993, Immunology today.

[13]  E. Unanue,et al.  A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak. , 1996, Journal of immunology.

[14]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[15]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[16]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[17]  P. Allen,et al.  Endogenous altered peptide ligands can affect peripheral T cell responses , 1996, The Journal of experimental medicine.

[18]  J. Strominger,et al.  The dichotomy of peptide presentation by class I and class II MHC proteins. , 1993, Chemical immunology.

[19]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[20]  Mark M. Davis,et al.  How αβ T-cell receptors ‘see’ peptide/MHC complexes , 1993 .

[21]  Emil R. Unanue,et al.  Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell , 1994, Nature.

[22]  P. Marrack,et al.  Production of soluble MHC class II proteins with covalently bound single peptides , 1994, Nature.

[23]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[24]  E. Unanue,et al.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  O. Rötzschke,et al.  Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. , 1991, Immunology today.

[26]  T. Elliott,et al.  Assembly of MHC class I molecules analyzed in vitro , 1990, Cell.

[27]  Ursula Esser,et al.  Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics , 1992, Nature.

[28]  J. Berzofsky.  Designing Peptide Vaccines to Broaden Recognition and Enhance Potency , 1995, Annals of the New York Academy of Sciences.

[29]  E. Unanue,et al.  Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. , 1996, Journal of immunology.

[30]  M. Blackman,et al.  Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor , 1993, The Journal of experimental medicine.

[31]  D. Vignali,et al.  Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules , 1992, The Journal of experimental medicine.

[32]  H. Kalbacher,et al.  Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. , 1996, International immunology.

[33]  E. Unanue,et al.  Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. , 1985, Journal of immunology.

[34]  J. Strominger,et al.  Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor , 1994, The Journal of experimental medicine.

[35]  A. McMichael,et al.  A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. , 1992, Science.

[36]  M. Bevan,et al.  Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.

[37]  E. Unanue,et al.  Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. , 1997, Journal of immunology.

[38]  D. Wiley,et al.  Antigenic peptide binding by class I and class II histocompatibility proteins. , 1994, Structure.

[39]  E. Unanue,et al.  Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Strominger,et al.  The two membrane proximal domains of CD4 interact with the T cell receptor , 1996, The Journal of experimental medicine.

[41]  E. Nardin,et al.  The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases. , 1995, Advances in immunology.

[42]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[43]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[44]  H. Grey,et al.  Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.

[45]  D. Wiley,et al.  Antigenic peptide binding by class I and class II histocompatibility proteins. , 1994, Behring Institute Mitteilungen.

[46]  T. Hogg,et al.  The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. , 1994, International immunology.

[47]  M. Blackman,et al.  Contribution of the TCR alpha-chain to the differential recognition of bacterial and retroviral superantigens. , 1995, Journal of immunology.

[48]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[49]  C. Janeway,et al.  The specificity and orientation of a TCR to its peptide-MHC class II ligands. , 1996, Immunity.

[50]  M. Eichelberger,et al.  Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. , 1993, Journal of immunology.

[51]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[52]  H. Mcdevitt,et al.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[54]  E. Unanue,et al.  Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope , 1987, Nature.

[55]  D. Fremont,et al.  Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.

[56]  L. Adorini,et al.  Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. , 1991, Journal of immunology.